These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 16434463)
1. Free fatty acids increase androgen precursors in vivo. Mai K; Bobbert T; Kullmann V; Andres J; Rochlitz H; Osterhoff M; Weickert MO; Bähr V; Möhlig M; Pfeiffer AF; Diederich S; Spranger J J Clin Endocrinol Metab; 2006 Apr; 91(4):1501-7. PubMed ID: 16434463 [TBL] [Abstract][Full Text] [Related]
2. Intravenous lipid and heparin infusion-induced elevation in free fatty acids and triglycerides modifies circulating androgen levels in women: a randomized, controlled trial. Mai K; Bobbert T; Reinecke F; Andres J; Maser-Gluth C; Wudy SA; Möhlig M; Weickert MO; Hartmann MF; Schulte HM; Diederich S; Pfeiffer AF; Spranger J J Clin Endocrinol Metab; 2008 Oct; 93(10):3900-6. PubMed ID: 18664538 [TBL] [Abstract][Full Text] [Related]
3. Impact of glycemic variations on the regulation of androgen metabolism in obese women with polycystic ovary syndrome. Ludwig AK; Goharian LG; Dietze T; Tauchert S; Rudolf S; Diedrich K; Schweiger U; Oltmanns KM Fertil Steril; 2009 Jul; 92(1):271-6. PubMed ID: 18692843 [TBL] [Abstract][Full Text] [Related]
5. Oral dehydroepiandrosterone for adrenal androgen replacement: pharmacokinetics and peripheral conversion to androgens and estrogens in young healthy females after dexamethasone suppression. Arlt W; Justl HG; Callies F; Reincke M; Hübler D; Oettel M; Ernst M; Schulte HM; Allolio B J Clin Endocrinol Metab; 1998 Jun; 83(6):1928-34. PubMed ID: 9626121 [TBL] [Abstract][Full Text] [Related]
6. Physiological changes in dehydroepiandrosterone are not reflected by serum levels of active androgens and estrogens but of their metabolites: intracrinology. Labrie F; Bélanger A; Cusan L; Candas B J Clin Endocrinol Metab; 1997 Aug; 82(8):2403-9. PubMed ID: 9253308 [TBL] [Abstract][Full Text] [Related]
7. No effect of free fatty acids on adrenocorticotropin and cortisol secretion in healthy young men. Mai K; Bobbert T; Kullmann V; Andres J; Bähr V; Maser-Gluth C; Rochlitz H; Spranger J; Diederich S; Pfeiffer AF Metabolism; 2006 Aug; 55(8):1022-8. PubMed ID: 16839836 [TBL] [Abstract][Full Text] [Related]
8. Adrenal androgen production capacity remains high up to menopause in women with polycystic ovary syndrome. Puurunen J; Piltonen T; Jaakkola P; Ruokonen A; Morin-Papunen L; Tapanainen JS J Clin Endocrinol Metab; 2009 Jun; 94(6):1973-8. PubMed ID: 19318449 [TBL] [Abstract][Full Text] [Related]
9. Ovulation after glucocorticoid suppression of adrenal androgens in the polycystic ovary syndrome is not predicted by the basal dehydroepiandrosterone sulfate level. Azziz R; Black VY; Knochenhauer ES; Hines GA; Boots LR J Clin Endocrinol Metab; 1999 Mar; 84(3):946-50. PubMed ID: 10084576 [TBL] [Abstract][Full Text] [Related]
10. Corticotropin-releasing hormone: a potent androgen secretagogue in girls with hyperandrogenism after precocious pubarche. Ibáñez L; Potau N; Marcos MV; de Zegher F J Clin Endocrinol Metab; 1999 Dec; 84(12):4602-6. PubMed ID: 10599726 [TBL] [Abstract][Full Text] [Related]
11. Six-month oral dehydroepiandrosterone supplementation in early and late postmenopause. Stomati M; Monteleone P; Casarosa E; Quirici B; Puccetti S; Bernardi F; Genazzani AD; Rovati L; Luisi M; Genazzani AR Gynecol Endocrinol; 2000 Oct; 14(5):342-63. PubMed ID: 11109974 [TBL] [Abstract][Full Text] [Related]
12. Marked decline in serum concentrations of adrenal C19 sex steroid precursors and conjugated androgen metabolites during aging. Labrie F; Bélanger A; Cusan L; Gomez JL; Candas B J Clin Endocrinol Metab; 1997 Aug; 82(8):2396-402. PubMed ID: 9253307 [TBL] [Abstract][Full Text] [Related]
13. Impact of overnight dexamethasone suppression on the adrenal androgen response to an oral glucose tolerance test in women with and without polycystic ovary syndrome. Buyalos RP; Geffner ME; Azziz R; Judd HL Hum Reprod; 1997 Jun; 12(6):1138-41. PubMed ID: 9221990 [TBL] [Abstract][Full Text] [Related]
15. Effects of aging on adrenal function in the human: responsiveness and sensitivity of adrenal androgens and cortisol to adrenocorticotropin in premenopausal and postmenopausal women. Parker CR; Slayden SM; Azziz R; Crabbe SL; Hines GA; Boots LR; Bae S J Clin Endocrinol Metab; 2000 Jan; 85(1):48-54. PubMed ID: 10634362 [TBL] [Abstract][Full Text] [Related]
16. Flutamide suppresses adrenal steroidogenesis but has no effect on insulin resistance and secretion and lipid levels in overweight women with polycystic ovary syndrome. Vrbíková J; Hill M; Dvoráková K; Stanická S; Vondra K; Stárka L Gynecol Obstet Invest; 2004; 58(1):36-41. PubMed ID: 15087595 [TBL] [Abstract][Full Text] [Related]
17. Adrenal androgen production in response to adrenocorticotropin infusions in men. Parker CR; Azziz R; Potter HD; Boots LR Endocr Res; 1996 Nov; 22(4):717-22. PubMed ID: 8969932 [TBL] [Abstract][Full Text] [Related]
18. Effects of flutamide on pituitary and adrenal responsiveness to corticotrophin releasing factor (CRF). De Leo V; la Marca A; Lanzetta D; Cariello PL; D'Antona D; Morgante G Clin Endocrinol (Oxf); 1998 Jul; 49(1):85-9. PubMed ID: 9797851 [TBL] [Abstract][Full Text] [Related]
19. Androgen-related effects on peripheral glucose metabolism in women with congenital adrenal hyperplasia. Paula FJ; Gouveia LM; Paccola GM; Piccinato CE; Moreira AC; Foss MC Horm Metab Res; 1994 Nov; 26(11):552-6. PubMed ID: 7875653 [TBL] [Abstract][Full Text] [Related]
20. Prolactin has a direct effect on adrenal androgen secretion. Higuchi K; Nawata H; Maki T; Higashizima M; Kato K; Ibayashi H J Clin Endocrinol Metab; 1984 Oct; 59(4):714-8. PubMed ID: 6090494 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]